News & Articles

Articles Filter

Field

See more

Technique

Search within technique

Company

Search within company

Type of Content

2016 Articles found

25
Best match













Editorial ArticleLife Sciences

What next for CRISPR after first therapeutic approvals?

As we celebrate the first regulatory approval of a gene-editing based therapeutic, Casgevy™, for the treatment of sickle cell disease and transfusion-dependent β-thalassemia, we consider the gene-editing challenges that must be overcome before CRISPR gene-editing technology becomes a common treatment modality

View article